BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 28707958)

  • 21. A multi-center, comparative, phase 3 study to determine the efficacy of gadofosveset-enhanced magnetic resonance angiography for evaluation of renal artery disease.
    McGregor R; Vymazal J; Martinez-Lopez M; Neuwirth J; Salgado P; Beregi JP; Peduto A; de la Pena-Almaguer E; Slater GJ; Shamsi K; Parsons EC
    Eur J Radiol; 2008 Feb; 65(2):316-25. PubMed ID: 17499952
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gadofosveset-enhanced magnetic resonance angiography of the thoracic vasculature in the equilibrium phase: feasibility and impact of dose.
    Kim CY; Heye T; Bashir MR; Gebhard TA; Merkle EM
    J Comput Assist Tomogr; 2013; 37(5):732-6. PubMed ID: 24045249
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Continuously moving table aorto-iliofemoral run-off contrast-enhanced magnetic resonance angiography: image quality analysis in comparison to the multistep acquisition.
    Asbach P; Meade MD; Sattenberg RJ; Klessen C; Huppertz A; Heidenreich JO
    Acta Radiol; 2014 Apr; 55(3):266-72. PubMed ID: 24078458
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Use of blood pool agents with steady-state MRI to assess the vascular system.
    Thakor AS; Chung J; Patel P; Chan A; Ahmed A; McNeil G; Liu DM; Forster B; Klass D
    J Magn Reson Imaging; 2017 Jun; 45(6):1559-1572. PubMed ID: 28422344
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Whole-body MR angiography in patients with peripheral arterial disease.
    Nielsen YJ
    Dan Med Bull; 2010 Dec; 57(12):B4231. PubMed ID: 21122468
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Improved vessel delineation in keyhole time-resolved contrast-enhanced MR angiography using a gadolinium doped flush.
    Beranek-Chiu J; Froehlich JM; Wentz KU; Doert AN; Zollikofer CL; Eckhardt BP
    J Magn Reson Imaging; 2009 May; 29(5):1147-53. PubMed ID: 19388120
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Unmasking pedal arteries in patients with critical ischemia using time-resolved contrast-enhanced 3D MRA.
    Langer S; Krämer N; Mommertz G; Koeppel TA; Jacobs MJ; Wazirie NA; Ocklenburg C; Spüntrup E
    J Vasc Surg; 2009 May; 49(5):1196-202. PubMed ID: 19394548
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Time-resolved MR angiography in the evaluation of central thoracic venous occlusive disease.
    Nael K; Krishnam M; Ruehm SG; Michaely HJ; Laub G; Finn JP
    AJR Am J Roentgenol; 2009 Jun; 192(6):1731-8. PubMed ID: 19457842
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Thoracic magnetic resonance venography using Gadofosveset in patients with venous pathology-A comparative study of image quality and inter-rater variability.
    Åkesson M; Lehti L; Höglund P; Åkeson P; Wassélius J
    Phlebology; 2017 Aug; 32(7):453-458. PubMed ID: 27388453
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Systematic analysis of the geometry of a defined contrast medium bolus--implications for contrast enhanced 3D MR-angiography of thoracic vessels].
    Kreitner KF; Kunz RP; Weschler C; Ley S; Krummenauer F; Schreiber WG; Thelen M
    Rofo; 2005 May; 177(5):646-54. PubMed ID: 15871079
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 0.125 mm(3) spatial resolution steady-state MR angiography of the thighs with a blood pool contrast agent using the quadrature body coil only at 1.5 Tesla.
    Boschewitz JM; Hadizadeh DR; Kukuk GM; Meyer C; Wilhelm K; Koscielny A; Verrel F; Gieseke J; Schild HH; Willinek WA
    J Magn Reson Imaging; 2014 Oct; 40(4):996-1001. PubMed ID: 24845363
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Non-gadolinium-enhanced 3-dimensional magnetic resonance angiography for the evaluation of thoracic aortic disease: a preliminary experience.
    Srichai MB; Kim S; Axel L; Babb J; Hecht EM
    Tex Heart Inst J; 2010; 37(1):58-65. PubMed ID: 20200628
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Peripheral magnetic resonance angiography with continuous table movement in combination with high spatial and temporal resolution time-resolved MRA With a total single dose (0.1 mmol/kg) of gadobutrol at 3.0 T.
    Voth M; Haneder S; Huck K; Gutfleisch A; Schönberg SO; Michaely HJ
    Invest Radiol; 2009 Sep; 44(9):627-33. PubMed ID: 19652610
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MR angiography of infrapopliteal arteries in patients with peripheral arterial occlusive disease by using Gadofosveset at 3.0 T: diagnostic accuracy compared with selective DSA.
    Bonel HM; Saar B; Hoppe H; Keo HH; Husmann M; Nikolaou K; Ludwig K; Szucs-Farkas Z; Srivastav S; Kickuth R
    Radiology; 2009 Dec; 253(3):879-90. PubMed ID: 19864508
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Combined blood pool and extracellular contrast agents for pediatric and young adult cardiovascular magnetic resonance imaging.
    Johnson JT; Robinson JD; Deng J; Rigsby CK
    Pediatr Radiol; 2016 Dec; 46(13):1822-1830. PubMed ID: 27576457
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Highly accelerated first-pass contrast-enhanced magnetic resonance angiography of the peripheral vasculature: comparison of gadofosveset trisodium with gadopentetate dimeglumine contrast agents.
    Maki JH; Wang M; Wilson GJ; Shutske MG; Leiner T
    J Magn Reson Imaging; 2009 Nov; 30(5):1085-92. PubMed ID: 19856442
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Time-resolved contrast-enhanced MRA (TWIST) with gadofosveset trisodium in the classification of soft-tissue vascular anomalies in the head and neck in children following updated 2014 ISSVA classification: first report on systematic evaluation of MRI and TWIST in a cohort of 47 children.
    Higgins LJ; Koshy J; Mitchell SE; Weiss CR; Carson KA; Huisman TA; Tekes A
    Clin Radiol; 2016 Jan; 71(1):32-9. PubMed ID: 26474946
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Highly accelerated single breath-hold noncontrast thoracic MRA: evaluation in a clinical population.
    Lim RP; Winchester PA; Bruno MT; Xu J; Storey P; McGorty K; Sodickson DK; Srichai MB
    Invest Radiol; 2013 Mar; 48(3):145-51. PubMed ID: 23249647
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Time-resolved contrast-enhanced magnetic resonance angiography (CEMRA) of the left atrium-pulmonary veins complex with half dose of intravenous gadolinium-based contrast agent. Technical feasibility and comparison with a conventional CEMRA, full contrast dose protocol.
    Faggioni L; Zampa V; Ortori S; Picano E; De Lucia R; Soldati E; Bongiorni MG; Neri E; Bartolozzi C
    Eur J Radiol; 2012 Feb; 81(2):250-6. PubMed ID: 21353421
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Image analysis in time-resolved large field of view 3D MR-angiography at 3T.
    Frydrychowicz A; Bley TA; Zadeh ZA; Harloff A; Winterer JT; Hennig J; Langer M; Markl M
    J Magn Reson Imaging; 2008 Nov; 28(5):1116-24. PubMed ID: 18972352
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.